Skip to main content
. 2020 Sep 21;9(9):899. doi: 10.3390/antiox9090899

Table 2.

Laboratory data of RA patients and control subjects.

Control (n = 70) RA (n = 74)
Hemoglobin (g/dL) 13.2 ± 1.8 12.3 ± 1.7
Red blood cell count (mln/μL) 4.51 ± 0.49 4.42 ± 0.53
MCV 88.7 ± 7.6 84.8 ± 8.3
Platelet count (103/ μL) 336 ± 115 324 ± 120
White blood cells (103/ μL) 7.23 ± 2.04 7.84 ± 2.47
Total plasma protein (g/dL) 7.23 ± 0.68 6.98 ± 0,59
AST (U/L) 22.1 ± 11.1 24.5 ± 13.3
ALT (U/L) 24.7 ± 11.3 26.1 ± 28.6
Total cholesterol (mg/dL) 211 ± 32 185 ± 46
LDL-cholesterol (mg/dL) 123 ± 21 106 ± 36
HDL-cholesterol (mg/dL) 54 ± 15 58 ± 18
Non-HDL cholesterol (mg/dL) 157 ± 28 128.3 ± 41.6
Triglycerides (mg/dL) 132 ± 25 108 ± 48
Apolipoprotein A-I (μg/mL) 1.12 ± 0.02 1.05 ± 0.03
Apolipoprotein A-II (μg/mL) 0.03 ± 0.01 0.04 ± 0.02
ESR (mm/1 h) 5.6 ± 3.8 35.4 ± 25.8 ***
CRP (mg/L) 3.34 ± 0.76 27.9 ± 31.9 ***
MPO (ng/mL) 1.5 ± 1.2 54.5 ± 13.2 ***

*** p < 0.001.